Tumor Microenvironment: Tumor Infiltrating Lymphocyte Score Predicts Breast Cancer Outcome

VIENNA—Because harnessing the immune system is now proven as a way of managing breast cancer, clinicians should consider the role of tumor infiltrating lymphocytes, according to Giuseppe Curigliano MD PhD, Director of the Early Drug Development for Innovative Therapies Division at the European Institute of Oncology, Milan—who presented an update of their role in mediating immune pathways in cancer at the St Gallen Breast Cancer Conference. He gave Oncology Times reporter Sarah Maxwell his insights into how the “immunome” could be used as a target.